Earnings Call · Q3 FY2023·2023-08-02

Q3 23EPS +3.18%·Rev n/aQ2 23EPS +6.06%·Rev n/aQ1 23EPS +3.04%·Rev n/aQ4 22EPS +1.17%·Rev n/a⚠ consensus missing

Cencora, Inc. COR

Bennett Murphy — Senior Vice President, Head of Investor Relations and Treasury

Steven Collis — Chairman, President and Chief Executive Officer

Guided by our pharmaceutical-centric strategy, we advanced our business by focusing on 4 key areas

James Cleary — Executive Vice President and Chief Financial Officer

+1.2%1d on move date+2.6% vs SPY3d−2.0%5d−2.0%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more COR calls or request research access.

More COR calls Browse calls Request research access